Crossmark

Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12879-017-2284-1

Published Online: 2017-03-01

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rattanaumpawan, Pinyo http://orcid.org/0000-0002-2964-6732
Werarak, Peerawong

Jitmuang, Anupop

Kiratisin, Pattarachai

Thamlikitkul, Visanu
Funding

Funding for this research was provided by:

Merck Sharp and Dohme (Merck Investigator Studies Program (MSP))

Health System Research Institute (Thailand)

Faculty of Medicine Siriraj Hospital, Mahidol University (Chalermprakiat Grant)

Faculty of Medicine Siriraj Hospital, Mahidol University (Chalermprakiat grant)

Faculty of Medicine Siriraj Hospital, Mahidol University (Chalermprakiat Grant)

Faculty of Medicine Siriraj Hospital, Mahidol University (Chalermprakiat Grant)

Faculty of Medicine Siriraj Hospital, Mahidol University (Chalermprakiat Grant)

Document is current

Any future updates will be listed below